Miranda An

Miranda An

Auto-generated profile, based on publicly available information

Miranda An

University of California, Irvine, Beckman Laser Institute and Medical Clinic, Irvine, California, United States

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in The American Journal of Pathology
Verified
Journal Article
Closed access
MOMichael O'HAre
Michael O'HAre
DADhanesh Amarnani
Dhanesh Amarnani
HWHannah A.B. Whitmore
Hannah A.B. Whitmore
MAMiranda An
Miranda An
CMClaudia Marino
Claudia Marino
LKLeo A. Kim
Leo A. Kim

17 December 2020 in The American Journal of Pathology
Verified
Journal Article
Closed access
LGLucia Gonzalez-Buendia
Lucia Gonzalez-Buendia
SDSantiago Delgado-Tirado
Santiago Delgado-Tirado
MAMiranda An
Miranda An
MOMichael O'HAre
Michael O'HAre
DADhanesh Amarnani
Dhanesh Amarnani
LKLeo A. Kim
Leo A. Kim

20 April 2022 in Ophthalmology Science
Verified
Journal Article
Open access
SDSantiago Delgado-Tirado
Santiago Delgado-Tirado
LGLucia Gonzalez-Buendia
Lucia Gonzalez-Buendia
MAMiranda An
Miranda An
DADhanesh Amarnani
Dhanesh Amarnani
DIDaniela Isaacs-Bernal
Daniela Isaacs-Bernal
LKLeo A. Kim
Leo A. Kim
To test the efficacy of runt-related transcription factor 1 (RUNX1) inhibition with topical nanoemulsion containing Ro5-3335 (eNano-Ro5) in experimental ocular neovascularization. Preclinical experimental study. In vitro primary culture human retinal endothelial cell (HREC) culture. C57BL/6J 6- to 10-week-old male and female mice. We evaluated the effect of eNano-Ro5 in cell proliferation, cell toxicity, and migration of HRECs. We used an alkali burn model of corneal neovascularization and a laser-induced model of choroidal neovascularization to test in vivo efficacy of eNano-Ro5 in pathologic angiogenesis in mice. We used mass spectrometry to measure penetration of Ro5-3335 released from the nanoemulsion in ocular tissues. Neovascular area. RUNX1 inhibition reduced cell proliferation and migration in vitro. Mass spectrometry analysis revealed detectable levels of the active RUNX1 small-molecule inhibitor Ro5-3335 in the anterior and posterior segment of the mice eyes. Topical treatment with eNano-Ro5 significantly reduced corneal neovascularization and improved corneal wound healing after alkali burn. Choroidal neovascularization lesion size and leakage were significantly reduced after treatment with topical eNano-Ro5. Topical treatment with eNano-Ro5 is an effective and viable platform to deliver a small-molecule RUNX1 inhibitor. This route of administration offers advantages that could improve the management and outcomes of these sight-threatening conditions. Topical noninvasive delivery of RUNX1 inhibitor could be beneficial for many patients with pathologic ocular neovascularization.

1 August 2024 in Journal of Biomedical Optics
Verified
Journal Article
Open access
PDF file
LELilangi S. Ediriwickrema
Lilangi S. Ediriwickrema
SSShijun Sung
Shijun Sung
KMKaylyn C. Mattick
Kaylyn C. Mattick
MAMiranda B. An
Miranda B. An
CMClaire Malley
Claire Malley
ADAnthony J. Durkin
Anthony J. Durkin
Periocular inflammatory and infiltrative conditions are of particular importance given the proximity to the eye, thereby raising the risk for dry eyes, exposure keratopathy, eyelid malposition, blurry vision, eye pain, vision loss, double vision, and rarely, extension to the central nervous system. Diseases that affect the region include thyroid eye disease, rosacea, and eczema, as well as basal cell carcinoma, squamous cell carcinoma, melanoma, and vascular malformations. Clinical diagnosis and management of these diseases are oftentimes dependent on invasive, time-intensive, and costly procedures and testing, as well as immunotherapy, surgical resection, and periocular reconstruction. Non-invasive objective approaches to measuring local inflammation and infiltration are therefore needed to better quantify disease activity, progression, and treatment response.